Dual antiplatelet therapy for secondary stroke prevention: Use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke

Can Fam Physician. 2016 Aug;62(8):640-5.

Authors

Karolina Koziol¹, Vanessa Van der Merwe², Erin Yakiwchuk³, Lynette Kosar⁴

Affiliations

¹ Pharmacist for the Saskatoon Health Region in Saskatchewan.
² Clinical Assistant Professor for the Geriatric Evaluation and Management Program for the Saskatoon Health Region.
³ Clinical coordinator in the Pharmacy Department, and a pharmacist for the Geriatric Evaluation and Management Program, for the Saskatoon Health Region.
⁴ Information Support Pharmacist for the RxFiles Academic Detailing Program for the Saskatoon Health Region. lynette@rxfiles.ca.

PMID: 27521393
PMCID: PMC4982726

No abstract available

Publication types

Case Reports
Review

MeSH terms

Aged, 80 and over
Aspirin / administration & dosage*
Aspirin / adverse effects
Cerebral Infarction / diagnostic imaging
Cerebral Infarction / drug therapy*
Clopidogrel
Drug Therapy, Combination
Female
Humans
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Aggregation Inhibitors / adverse effects
Randomized Controlled Trials as Topic
Secondary Prevention / methods*
Ticlopidine / administration & dosage
Ticlopidine / adverse effects
Ticlopidine / analogs & derivatives*
Tomography, X-Ray Computed
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine
Aspirin